Are you Dr. McMillan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 3 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
41 Mall Rd
Burlington, MA 01805Phone+1 781-744-5238Fax+1 781-744-2930- Is this information wrong?
Summary
- Dr. Hugh McMillan, MD is a Child Neurologist in Burlington, Massachusetts.
Certifications & Licensure
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- 81 citationsOnasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.Kevin A Strauss, Michelle A Farrar, Francesco Muntoni, Kayoko Saito, Jerry R Mendell, Laurent Servais, Hugh J McMillan, Richard S Finkel, Kathryn J Swoboda, Jennifer M...> ;Nature Medicine. 2022 Jul 1
- 70 citationsOnasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.Kevin A Strauss, Michelle A Farrar, Francesco Muntoni, Kayoko Saito, Jerry R Mendell, Laurent Servais, Hugh J McMillan, Richard S Finkel, Kathryn J Swoboda, Jennifer M...> ;Nature Medicine. 2022 Jul 1
- 10 citationsOnasemnogene abeparvovec for the treatment of spinal muscular atrophy.Hugh J McMillan, Crystal M Proud, Michelle A Farrar, Ian E Alexander, Francesco Muntoni, Laurent Servais> ;Expert Opinion on Biological Therapy. 2022 Sep 1
- Join now to see all
Press Mentions
- Welcome Dr. Hugh McMillanMarch 15th, 2021
Golden Lake Family's SMA Treatment Miracle for One-Year-Old Son May Be Coming TrueJanuary 9th, 2021- Novartis' Spinal Muscular Atrophy Drug Approved in CanadaDecember 17th, 2020
- Join now to see all
